Jade Biosciences (JBIO) EBIT (2020 - 2026)
Jade Biosciences (JBIO) posted EBIT of -$43.4 million for Q1 2026, down 24.2% on a QoQ basis from -$35.0 million in Q4 2025, and down 85.79% year-over-year from -$305.7 million in Q1 2025.
Jade Biosciences (JBIO) EBIT (2020 - 2026) Analysis & Trends
Jade Biosciences' EBIT history runs 7 years deep, the most recent figure standing at -$43.4 million for Q1 2026.
- Quarterly EBIT fell 85.79% year-over-year to -$43.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$133.6 million (down 32.75% YoY) and the FY2025 annual result came in at -$113.5 million, down 52.21% from the prior year.
- EBIT was -$43.4 million for Q1 2026 at Jade Biosciences, down from -$35.0 million in the prior quarter.
- Across five years, EBIT topped out at -$11.0 million in Q1 2022 and bottomed at -$43.4 million in Q1 2026.
- A 5-year average of -$23.1 million and a median of -$22.1 million in 2023 frame the typical range for EBIT.
- Annual changes were most pronounced in 2022 — EBIT sank 296.37% — and 2024, when it gained 27.2%.
- Jade Biosciences' EBIT stood at -$15.9 million in 2022, then slumped by 39.2% to -$22.1 million in 2023, then slumped by 61.05% to -$35.5 million in 2024, then advanced by 1.57% to -$35.0 million in 2025, then declined by 24.2% to -$43.4 million in 2026.
- Business Quant data shows JBIO's EBIT at -$43.4 million in Q1 2026, -$35.0 million in Q4 2025, and -$27.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Jade Biosciences | 16.25 Mn | 16.25 Mn | - | -43.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -43.45 Mn |
| Dec 31, 2025 | -34.98 Mn |
| Sep 30, 2025 | -27.40 Mn |
| Jun 30, 2025 | -27.78 Mn |
| Mar 31, 2025 | -23.38 Mn |
| Dec 31, 2024 | -35.54 Mn |
| Sep 30, 2024 | -15.56 Mn |
| Jun 30, 2024 | -26.17 Mn |
| Mar 31, 2024 | -24.62 Mn |
| Dec 31, 2023 | -22.07 Mn |
| Sep 30, 2023 | -21.37 Mn |
| Jun 30, 2023 | -20.34 Mn |
| Mar 31, 2023 | -17.64 Mn |
| Dec 31, 2022 | -15.85 Mn |
| Sep 30, 2022 | -14.15 Mn |
| Jun 30, 2022 | -12.22 Mn |
| Mar 31, 2022 | -11.02 Mn |
| Dec 31, 2021 | -8.27 Mn |
| Sep 30, 2021 | -6.20 Mn |
| Jun 30, 2021 | -5.77 Mn |